Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

CYCLOPHOSPHAMIDE

CYCLOPHOSPHAMIDE

Standard Dose
200MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview CYCLOPHOSPHAMIDE is listed in Drugs@FDA under application 088372 (ANDA).

Marketing status: Discontinued Active ingredient CYCLOPHOSPHAMIDE Form and strength INJECTABLE;INJECTION - 200MG/VIAL Sponsor BAXTER HLTHCARE Submission history Latest submission status date: 1991-12-03 00:00:00.

Structured Monograph

Clinical summary

Approval overview CYCLOPHOSPHAMIDE is listed in Drugs@FDA under application 088372 (ANDA). Marketing status: Discontinued Active ingredient CYCLOPHOSPHAMIDE Form and strength INJECTABLE;INJECTION - 200MG/VIAL Sponsor BAXTER HLTHCARE Submission history Latest submission status date: 1991-12-03 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.